Target- |
MechanismCell replacements |
|
|
|
Inactive Indication- |
Drug Highest PhaseEarly Phase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismCell replacements |
Active Org.- |
|
Active Indication- |
Inactive Indication- |
Drug Highest Phase- |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Genmedicn Biopharma Inc.
0 Patents (Medical) associated with Genmedicn Biopharma Inc.
100 Deals associated with Genmedicn Biopharma Inc.
100 Translational Medicine associated with Genmedicn Biopharma Inc.